IMI moves forward

Abstract

689 To the Editor: As members of the Governing Board of the Innovative Medicines Initiative (IMI), we wish to respond to two recent articles published in Nature Biotechnology that cast unfounded gloom over IMI1,2. In the June issue, Gunjan Sinha reports on a series of incorrect allegations on the funding rules and intellectual property (IP) policy of IMI1… (More)
DOI: 10.1038/nbt.1944

Topics

1 Figure or Table

Cite this paper

@article{Strohmeier2011IMIMF, title={IMI moves forward}, author={Rudolf Strohmeier and Ruxandra Draghia-Akli and Andrzej Rys and Pedro Ortun Silvan and Theodius Lennon and Carlo Incerti and Richard Bergstr{\"o}m and Salahdine Chibout and Roch Doliveux and Peter Hongaard Andersen}, journal={Nature Biotechnology}, year={2011}, volume={29}, pages={689-690} }